Correction: The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma

VitB5 level becomes limiting in sarcomas. It is regulated by the pantetheinase activity of VNN1. VNN1 expression in sarcomas is associated with better prognosis and immune infiltration. In mice, complementation with pantethine, a vitB5 precursor, boosts antitumor immunity.

Detalles Bibliográficos
Autores principales: Miallot, Richard, Millet, Virginie, Roger, Anais, Fenouil, Romain, Tardivel, Catherine, Martin, Jean-Charles, Tranchida, Fabrice, Shintu, Laetitia, Berchard, Paul, Sousa Lanza, Juliane, Malissen, Bernard, Henri, Sandrine, Ugolini, Sophie, Dutour, Aurélie, Finetti, Pascal, Bertucci, François, Blay, Jean-Yves, Galland, Franck, Naquet, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2023
Materias:
Corrections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690990/
https://www.ncbi.nlm.nih.gov/pubmed/38030222
http://dx.doi.org/10.26508/lsa.202302479
Descripción
Sumario:VitB5 level becomes limiting in sarcomas. It is regulated by the pantetheinase activity of VNN1. VNN1 expression in sarcomas is associated with better prognosis and immune infiltration. In mice, complementation with pantethine, a vitB5 precursor, boosts antitumor immunity.

Ejemplares similares